We apply a targeted three-pillar strategy to what we do, combining the strengths of providing high
quality products that meet or exceed international standards, with increasing accessibility of medicine that is
both affordable and geographically accessible. This is strengthened by a compassionate and
empathetic approach on both corporate and personal levels.
Quality healthcare demands are increasing exponentially worldwide. With this in mind, Julphar Diabetes is committed to achieving our mission without compromising quality. Our practices are guided by international requirements set forth by the regulatory authorities such as the Ministry of Health and the US Food and Drug Administration (US-FDA). This has lead us to achieve ISO9001 and ISO14001 accreditation, EU-GMP and GLP certifications.
Our goal is to make medications more Accessible. To ascertain this, we have developed a novel tiered pricing policy which enables us to provide affordable medications to economically challenged areas across the MEAA. We are also able to access areas which are geographically underserved.
Our corporate responsibility to deliver better
healthcare to communities in our region is of prime importance. We believe that with the right information,
diabetes can be managed effectively.
One of the most important initiatives undertaken every year by
Julphar Diabetes is to sponsor a regional diabetes camp for
diabetic children in order to provide them with the most up-to-date
management techniques which will positively impact their quality